This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Congenital Bleeding Disorder, Haemophilia A With Inhibitors or Haemophilia B With Inhibitors
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

This study is conducted in Japan. The aim of this registry study is to observe the use of single dose and multi-dose use of eptacog alpha (NovoSeven®) and to compare short-term outcomes, including effectiveness, safety, quality of life and treatment satisfaction with the approved treatments.

Provided treatments

  • Drug: eptacog alfa (activated)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01586936. The sponsor of the trial is Novo Nordisk A/S and it is looking for 9 volunteers for the current phase.
Official trial title:
Special Survey of Production of Antibody Against Coagulation